Advantek Biopharm

Advantek Biopharm is a biotechnology company focused on the development and manufacturing of innovative biologics, including monoclonal antibodies and recombinant proteins. The company operates as both a drug developer and a Contract Development and Manufacturing Organization (CDMO), leveraging its proprietary high-efficiency cell line development and protein expression platforms. Advantek Biopharm aims to accelerate the transition of therapeutic candidates from discovery to clinical production with a focus on oncology and autoimmune indications. Headquartered in China, the company maintains state-of-the-art facilities designed to meet international GMP standards for global biopharmaceutical development.